Centre for Clinical and Community Applications of Health Psychology, University of Southampton, Southampton, UK.
Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
J Antimicrob Chemother. 2019 Nov 1;74(11):3362-3370. doi: 10.1093/jac/dkz333.
Hospital antimicrobial stewardship strategies, such as 'Start Smart, Then Focus' in the UK, balance the need for prompt, effective antibiotic treatment with the need to limit antibiotic overuse using 'review and revise'. However, only a minority of review decisions are to stop antibiotics. Research suggests that this is due to both behavioural and organizational factors.
To develop and optimize the Antibiotic Review Kit (ARK) intervention. ARK is a complex digital, organizational and behavioural intervention that supports implementation of 'review and revise' to help healthcare professionals safely stop unnecessary antibiotics.
A theory-, evidence- and person-based approach was used to develop and optimize ARK and its implementation. This was done through iterative stakeholder consultation and in-depth qualitative research with doctors, nurses and pharmacists in UK hospitals. Barriers to and facilitators of the intervention and its implementation, and ways to address them, were identified and then used to inform the intervention's development.
A key barrier to stopping antibiotics was reportedly a lack of information about the original prescriber's rationale for and their degree of certainty about the need for antibiotics. An integral component of ARK was the development and optimization of a Decision Aid and its implementation to increase transparency around initial prescribing decisions.
The key output of this research is a digital and behavioural intervention targeting important barriers to stopping antibiotics at review (see http://bsac-vle.com/ark-the-antibiotic-review-kit/ and http://antibioticreviewkit.org.uk/). ARK will be evaluated in a feasibility study and, if successful, a stepped-wedge cluster-randomized controlled trial at acute hospitals across the NHS.
医院抗菌药物管理策略,如英国的“明智启动,然后聚焦”,平衡了迅速、有效使用抗生素治疗的需求与限制抗生素过度使用的需求,即“审查和修改”。然而,只有少数审查决定是停止使用抗生素。研究表明,这是由于行为和组织因素造成的。
开发和优化抗生素审查工具包(ARK)干预措施。ARK 是一种复杂的数字、组织和行为干预措施,支持实施“审查和修改”,以帮助医疗保健专业人员安全地停止不必要的抗生素。
采用基于理论、证据和人的方法来开发和优化 ARK 及其实施。这是通过与英国医院的医生、护士和药剂师进行迭代的利益相关者协商和深入的定性研究来完成的。确定了干预措施及其实施的障碍和促进因素,以及解决这些障碍和促进因素的方法,然后利用这些方法来指导干预措施的发展。
据报道,停止使用抗生素的一个主要障碍是缺乏关于原始开方者用药理由和对使用抗生素必要性的确信程度的信息。ARK 的一个重要组成部分是开发和优化决策辅助工具及其实施,以增加初始处方决策的透明度。
这项研究的主要成果是一种数字和行为干预措施,针对审查时停止使用抗生素的重要障碍(请参见 http://bsac-vle.com/ark-the-antibiotic-review-kit/ 和 http://antibioticreviewkit.org.uk/)。如果在可行性研究中取得成功,ARK 将在英国国民保健署(NHS)的急性医院进行阶梯式楔形集群随机对照试验。